Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR)
Protocol ID
ECREST
Disease (Sub Disease)
Solid tumours
CNS tumours
Diagnosis Stage
Relapse/refractory
Location
NSW, QLD
Sponsor
Sydney Children's Hospital Network
Collaborators
Engeneic Pty Limited
Trial Status
Open
Sites
The Children's Hospital at Westmead
Queensland Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
2 Years to 21 Years
International registry ID's
NCT02687386
Back to Registry
Study Title A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR)
Protocol ID ECREST
Disease (Sub Disease) Solid tumours
CNS tumours
Diagnosis Stage Relapse/refractory
Location NSW / QLD
Sponsor Sydney Children's Hospital Network
Collaborators Engeneic Pty Limited
Links https://clinicaltrials.gov/ct2/show/NCT02687386
Trial Status Open
Trial Open Date 08/02/2016
Sites The Children's Hospital at Westmead / Queensland Children's Hospital / Sydney Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility 2 Years to 21 Years
International registry ID's NCT02687386